Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
9.47
+0.26 (2.82%)
At close: May 6, 2026, 4:00 PM EDT
9.50
+0.03 (0.29%)
After-hours: May 6, 2026, 7:04 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $573.22 million as of May 6, 2026. Its market cap has increased by 566.49% in one year.
Market Cap
573.22M
Enterprise Value
323.00M
1-Year Change
566.49%
Ranking
Category
Stock Price
$9.47
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $573.22M, a decrease of -36.17%. That is a compound annual growth rate of -18.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 557.48M | 3.81% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entrada Therapeutics | 576.91M |
| ProKidney | 566.18M |
| Crescent Biopharma | 564.89M |
| Candel Therapeutics | 564.00M |
| Ginkgo Bioworks Holdings | 557.63M |
| Tectonic Therapeutic | 551.88M |
| Eikon Therapeutics | 549.24M |
| MiMedx Group | 545.89M |